Sebastiano Buti

KIM-1 in oligometastatic ccRCC. KIM-1 and ctDNA are independently prognostic. @DrChoueiri @VincentWenxinXu @PavlosMsaouel @lilli_ash @Clara__Steiner #GU26 @EUplatinum @ASCO @OncoAlert

When is immunotherapy too much? The case of favorable-risk metastatic ... sciencedirect.com/science/articl…

Early EV dose reduction in advanced urothelial cancer ↘️ treatment interruption risk by half, yet survival stayed the same. @JAMAOnc @OncoAlert @WorldBladderCan @Uromigos jamanetwork.com/journals/jamao…

In a new study published in @CCR_AACR, @DanaFarber researchers found the effects of immunotherapy can last after treatment stops in patients with advanced non-small cell lung cancer. @DFarberThoracic Read more: bit.ly/3GhpAhM

BREAKING from @NEJM In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is : 🔘Noninferior to full-dose (5 mg BID) for VTE recurrence 🔘Lower bleeding risk (12.1% vs. 15.6%) 🔘Safer extended anticoagulation, same protection. #Thrombosis #cancer @OncoAlert @Cihan_Ay_MD DOI: 10.1056/NEJMoa2416112

20 years ago, metastatic melanoma meant death in a year. Today? 🔸 10-yr Overall Survival: 43% (nivo+ipi) 🔸 10-yr Melanoma-Specific Survival: 52% This isn’t improvement. It’s a revolution. Believe in science. #Melanoma #Immunotherapy #Oncology #Cancer @NEJM @asco @myESMO @sitcancer @OncoAlert @oncodaily nejm.org/doi/full/10.10…

GRANT Score has beeen validated also in patients with resected papillary RCC pubmed.ncbi.nlm.nih.gov/40129395/

50 years of vaccines = 154 million lives saved! Since 1974, childhood vaccines have been the biggest driver of infant survival, preventing 40% of infant deaths globally. Immunization isn’t just protection—it’s a lifesaver. #VaccinesWork #PublicHealth @TheLancet @WHO @CDCgov @EricTopol @Atul_Gawande thelancet.com/journals/lance…

💊 7 vs. 14 Days of Antibiotics? For bloodstream infections, 7 days = 14 days in 90-day mortality! @NEJM Mortalities: 7 days: 14.5% 14 days: 16.1% Less is more!!! @oergonul1 nejm.org/doi/full/10.10…

The Italian hospital medical profession is broken too - The Lancet Regional Health – Europe thelancet.com/journals/lanep…

This morning I have found this on my desk... I am so proud of this achievement! 😁 Thanks 🙏 to all investigators & @EUplatinum for supporting Academic Research in GU cancers. Stay tuned 🛜 for other news from TIDE-A trial! @Uroweb @urofocus @OncoAlert @oncodaily @GUOncologyNow @OncLive

Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney - Clinical Genitourinary Cancer clinical-genitourinary-cancer.com/article/S1558-…

The potential of RBC-based scores to improve prognostic systems in metastatic renal cell carcinoma. Identifying patients with better prognosis and exploring molecular correlates could refine treatment strategies, #mRCC #CancerResearch #Oncology #IUCS @OncoAlert @OncoViews

@gbanna74 @OncoAlert @OncoViews @RebuzziSara @GFornarini @therealmarcodoc @PasRescigno @biostat84 @Uroweb @urologysummit @gu_onc We are delighted to inform you that your post has been successfully published on Oncodaily. Thank you for sharing such valuable content. oncodaily.com/url/123419

RBC-based scores improving prognostic systems in metastatic RCC - @gbanna74 @OncoViews @RebuzziSara @Sebastiano_Buti oncodaily.com/url/123419 #Cancer #OncoDaily #Oncology #NHS #CancerCare

Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab pubmed.ncbi.nlm.nih.gov/39155821/

1/ 🚨 Just in @EUplatinum , our study on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma. Effort co-led with @TalalZarif1, with amazing mentorship from @DrDanielHeng @DrChoueiri sciencedirect.com/science/articl… @DanaFarber_GU @YaleMed @OncoAlert

ITALIAN REGISTRY ON RARE UROLOGICAL TUMORS (MEET-URO-23): THE FIRST ANALYSIS ON COLLECTING DUCT CARCINOMA OF THE KIDNEY - Clinical Genitourinary Cancer clinical-genitourinary-cancer.com/article/S1558-…

Intersecting Blood Cytokines With Cholesterol Parameters to ... : Journal of Immunotherapy journals.lww.com/immunotherapy-…

Amazing performance by the stellar @CityofHope_GU team’s junior investigators👉Two back to back @NatureMedicine original research articles from their IIT studies. Congrats @EbrahimiHedyeh @NazliDizman & team and the mega-mentor @montypal Cc @ASCO @OncoAlert @Uromigos @kidneycan